Cigna Group director awarded 782 common shares

WISEMAN ERIC C reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

WISEMAN ERIC C reported acquisition or exercise transactions in this Form 4 filing.

Cigna Group director Eric C. Wiseman received an equity award of 782 shares of common stock, recorded at a price of $0.00 per share as a compensation grant. Following this award, he directly holds 23,940 common shares. The filing notes that his economic interest also includes cash-settled hypothetical shares tied to Cigna’s stock value, which are not counted in the reported share totals.

Insider Trade Summary

Grant/Award: 782 shares

Grant/Award 1 txn

Insider WISEMAN ERIC C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $.01 Par Value	782	$0.00	$0.00

Holdings After Transaction: Common Stock, $.01 Par Value — 23,940 shares (Direct)

Footnotes (1)

1. F1. The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026.

Key Figures

Shares granted: 782 shares Grant price: $0.00 per share Shares owned after: 23,940 shares +1 more

4 metrics

Shares granted 782 shares Equity award of common stock on April 22, 2026

Grant price $0.00 per share Stated transaction price for awarded shares

Shares owned after 23,940 shares Direct common stock holdings following the grant

Transaction direction Acquisition (grant/award) SEC transaction code A for the reported entry

Key Terms

hypothetical shares of common stock, settled in cash, Section 16 filings, proxy statement

4 terms

hypothetical shares of common stock financial

"The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly..."

settled in cash financial

"Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock..."

Section 16 filings regulatory

"For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group..."

proxy statement regulatory

"...and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026."

A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cigna Group (CI) director Eric Wiseman report in this Form 4?

Eric C. Wiseman reported receiving an equity award of 782 Cigna Group common shares. This is a compensation-related grant, not an open-market trade, and increases his directly held stake in the company to 23,940 shares after the transaction.

Is the Eric Wiseman Form 4 transaction in Cigna Group (CI) a purchase or a grant?

The transaction is a grant, not a market purchase. Wiseman received 782 common shares at a stated price of $0.00 per share as a compensation award, categorized as a grant or other acquisition under SEC transaction code A.

How many Cigna Group (CI) shares does Eric Wiseman hold after this Form 4?

After the reported grant, Eric Wiseman directly holds 23,940 Cigna Group common shares. This total reflects his post-transaction direct ownership reported in Table I and does not include separate hypothetical, cash-settled share units referenced in the filing footnote.

Does Eric Wiseman’s Cigna Group (CI) filing include hypothetical share units?

Yes. The footnote explains his economic interest also includes hypothetical Cigna common share units. These track the stock’s value but are cash-settled at separation, so SEC rules exclude them from Table I share totals reported in this Form 4.

What does transaction code A mean in the Cigna Group (CI) Form 4?

Transaction code A in this filing indicates a grant, award, or other acquisition of shares. For Eric Wiseman, it represents a compensation-related grant of 782 Cigna common shares rather than an open-market buy or sell transaction executed on a stock exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 04:47 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WISEMAN ERIC C

(Last) (First) (Middle)

900 COTTAGE GROVE ROAD

(Street)

BLOOMFIELD CONNECTICUT 06002

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	04/22/2026		A		782	A	$0	23,940(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026.

Remarks:

Exhibit 24 - Power of Attorney

	Tyler Gratton, attorney-in-fact	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)